116 related articles for article (PubMed ID: 23811291)
1. New long circulating magnetoliposomes as contrast agents for detection of ischemia-reperfusion injuries by MRI.
Martins MB; Corvo ML; Marcelino P; Marinho HS; Feio G; Carvalho A
Nanomedicine; 2014 Jan; 10(1):207-14. PubMed ID: 23811291
[TBL] [Abstract][Full Text] [Related]
2. Enhanced contrast efficiency in MRI by PEGylated magnetoliposomes loaded with PEGylated SPION: effect of SPION coating and micro-environment.
Carvalho A; Martins MB; Corvo ML; Feio G
Mater Sci Eng C Mater Biol Appl; 2014 Oct; 43():521-6. PubMed ID: 25175245
[TBL] [Abstract][Full Text] [Related]
3. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
4. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
5. Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis.
Yan C; Wu Y; Feng J; Chen W; Liu X; Hao P; Yang R; Zhang J; Lin B; Xu Y; Liu R
Int J Nanomedicine; 2013; 8():245-55. PubMed ID: 23345972
[TBL] [Abstract][Full Text] [Related]
6. Development of New Contrast Agents for Imaging Function and Metabolism by Magnetic Resonance Imaging.
Carvalho A; Gonçalves MC; Corvo ML; Martins MBF
Magn Reson Insights; 2017; 10():1178623X17722134. PubMed ID: 28804244
[TBL] [Abstract][Full Text] [Related]
7. Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI.
Martínez-González R; Estelrich J; Busquets MA
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27472319
[TBL] [Abstract][Full Text] [Related]
8. The effect of superparamagnetic iron oxide nanoparticles surface engineering on relaxivity of magnetoliposome.
Khaleghi S; Rahbarizadeh F; Ahmadvand D; Malek M; Madaah Hosseini HR
Contrast Media Mol Imaging; 2016 Sep; 11(5):340-349. PubMed ID: 27307214
[TBL] [Abstract][Full Text] [Related]
9. Solid and aqueous magnetoliposomes as nanocarriers for a new potential drug active against breast cancer.
Rodrigues ARO; Mendes PMF; Silva PML; Machado VA; Almeida BG; Araújo JP; Queiroz MRP; Castanheira EMS; Coutinho PJG
Colloids Surf B Biointerfaces; 2017 Oct; 158():460-468. PubMed ID: 28732311
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of peri-tumoral vessels surrounding colorectal liver metastases after intravenous injection of extruded magnetoliposomes in rats: correlation with 3T MRI and histopathology.
Coenegrachts K; van Werven J; ter Beek L; Mzallassi Z; Bögels M; van Gulik T; Van Den Berghe I; Nederveen A; Stoker J; Rigauts H; Soenen S; De Cuyper M
JBR-BTR; 2010; 93(2):87-91. PubMed ID: 20524517
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of magnetoliposomes for MRI contrast enhancement.
Faria MR; Cruz MM; Gonçalves MC; Carvalho A; Feio G; Martins MB
Int J Pharm; 2013 Mar; 446(1-2):183-90. PubMed ID: 23422275
[TBL] [Abstract][Full Text] [Related]
12. Tracking T-cells in vivo with a new nano-sized MRI contrast agent.
Liu L; Ye Q; Wu Y; Hsieh WY; Chen CL; Shen HH; Wang SJ; Zhang H; Hitchens TK; Ho C
Nanomedicine; 2012 Nov; 8(8):1345-54. PubMed ID: 22406186
[TBL] [Abstract][Full Text] [Related]
13. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
14. Relaxivities of magnetoliposomes: the effect of cholesterol.
Carvalho A; Gonçalves MC; Martins MB; Meixedo D; Feio G
Magn Reson Imaging; 2013 May; 31(4):610-2. PubMed ID: 23333578
[TBL] [Abstract][Full Text] [Related]
15. Short- vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents.
Bulte JW; de Cuyper M; Despres D; Frank JA
J Magn Reson Imaging; 1999 Feb; 9(2):329-35. PubMed ID: 10077033
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol.
Ruiz A; Hernández Y; Cabal C; González E; Veintemillas-Verdaguer S; Martínez E; Morales MP
Nanoscale; 2013 Dec; 5(23):11400-8. PubMed ID: 23832394
[TBL] [Abstract][Full Text] [Related]
17. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
[TBL] [Abstract][Full Text] [Related]
18. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging.
Martina MS; Fortin JP; Ménager C; Clément O; Barratt G; Grabielle-Madelmont C; Gazeau F; Cabuil V; Lesieur S
J Am Chem Soc; 2005 Aug; 127(30):10676-85. PubMed ID: 16045355
[TBL] [Abstract][Full Text] [Related]
19. MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: a tool for image-guided local drug delivery.
Lorenzato C; Cernicanu A; Meyre ME; Germain M; Pottier A; Levy L; de Senneville BD; Bos C; Moonen C; Smirnov P
Contrast Media Mol Imaging; 2013; 8(2):185-92. PubMed ID: 23281291
[TBL] [Abstract][Full Text] [Related]
20. Optimized synthesis of 100 nm diameter magnetoliposomes with high content of maghemite particles and high MRI effect.
Garnier B; Tan S; Miraux S; Bled E; Brisson AR
Contrast Media Mol Imaging; 2012; 7(2):231-9. PubMed ID: 22434636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
